Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New immunotherapy combo aims to outperform keytruda in melanoma

NCT ID NCT05352672

Disease control Sponsor: Regeneron Pharmaceuticals Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This phase 3 trial tests whether combining two immunotherapy drugs, fianlimab and cemiplimab, works better than the standard drug pembrolizumab for people with advanced melanoma that cannot be surgically removed. About 1,500 adults and adolescents who have not had prior treatment for advanced disease are participating. The study measures how long the cancer stays under control and overall survival.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
fianlimab and cemiplimab (combination immunotherapy drugs)
What this could lead to
If successful, this combination could offer a new first-line treatment option for advanced melanoma, potentially improving survival and tumor control.
What could go wrong
This is a large phase 3 trial, but the experimental combo may not prove better than the current standard (pembrolizumab). Side effects from immunotherapy can be serious.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

1,546 people

The number who actually took part.

Started

Jul 2022

Expected to finish

Sep 2031

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

12 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Key Inclusion Criteria: 1. Age ≥12 years on the date of providing informed consent 2. Patients with histologically confirmed unresectable Stage III and Stage IV (metastatic) melanoma (AJCC, 8th revised edition) who have not received prior systemic therapy for advanced unresectable disease 1. Patients who received adjuvant and/or neoadjuvant systemic therapies are eligible if they did not have evidence of progression or recurrence of disease and/or discontinued due to occurrence of unmanageable imAEs ≥ grade 3 (with the exclusion of endocrinopathies which are fully controlled by hormone replacement) while on such therapies. Also, patients must have had a treatment-free and disease-free interval of \>6 months. Accrual of these patients is limited to approximately 10% of the total population enrolled. 2. Patients with acral and mucosal melanomas are eligible. Accrual will be limited to 10% of the total population. 3. Measurable disease per RECIST v1.1 1. Previously irradiated lesions can only be counted as target lesions if they have been demonstrated to progress and no other target lesion is available 2. Cutaneous lesions should be evaluated as non-target lesions 4. Performance status: 1. For adult patients: Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1 2. For pediatric patients: Karnofsky performance status ≥70 (patients ≥16 years) or Lansky performance status ≥70 (patients ≤16 years) 5. Anticipated life expectancy of at least 3 months Key Exclusion Criteria: 1. Uveal melanoma 2. Ongoing or recent (within 2 years) evidence of an autoimmune disease that required systemic treatment with immunosuppressive agents. The following are non-exclusionary: vitiligo, childhood asthma that has resolved, residual hypothyroidism that requires only hormone replacement, psoriasis not requiring systemic treatment. 3. Uncontrolled infection with human immunodeficiency virus (HIV), hepatitis B (HBV) or hepatitis C virus (HCV) infection; or diagnosis of immunodeficiency that is related to, or results in chronic infection 4. Unknown BRAF V600 mutation status as described in the protocol 5. Systemic immune suppression: 1. Use of immunosuppressive doses of corticosteroids (\>10mg of prednisone per day or equivalent) within 14 days of the first dose of study medication. Physiologic replacement doses are allowed up to and including 10mg of prednisone/day or equivalent. Inhaled or topical steroids are permitted, if they are not for treatment of an autoimmune disorder. 2. Other clinically relevant forms of systemic immune suppression 6. Treatment with other anti-cancer therapy including immuno- therapy, chemotherapy, major surgery or biological therapy within 21 days prior to the first dose of trial treatment. Adjuvant hormonotherapy used for breast cancer or other hormone-sensitive cancers in long term remission is allowed. 7. History or current evidence of significant (CTCAE Grade ≥2) local or systemic infection (e. g., cellulitis, pneumonia, septicemia) requiring systemic antibiotic treatment within 14 days prior to the first dose of trial medication. 8. Active or untreated brain metastases or spinal cord compression. Patients with leptomeningeal disease are excluded. Patients with known brain metastases are eligible if they: 1. Received radiotherapy or another appropriate standard therapy for the brain metastases, 2. Have neurologically returned to baseline (except for residual signs and symptoms related to the CNS treatment) for at least 14 days prior to enrollment 3. Did not require immunosuppressive doses of corticosteroids therapy (\>10mg of prednisone per day or equivalent) in the 14 days prior to enrollment 4. Are asymptomatic with a single untreated brain metastasis \<10 mm in size 9. Participants with a history of myocarditis. Note: Other protocol-defined Inclusion/ Exclusion criteria apply

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Melanoma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

melanoma metastatic melanoma Neoplasm Metastasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Melanoma

Contacts and locations

Locations

  • AZ Groeninge

    Kortrijk, West-Vlaanderen, 8500, Belgium

  • AZ Nikolaas

    Sint-Niklaas, West-Vlaanderen, 9100, Belgium

  • Acad.Fridon Todua Medical Center- Research Institute of Clinical Medicine

    Tbilisi, 0112, Georgia

  • Alfred Hospital

    Melbourne, Victoria, 3004, Australia

  • Andrew Love Cancer Centre

    Geelong, Victoria, 3220, Australia

  • Animi Unidade de Tratamento Oncologico

    Lages, Santa Catarina, 88501-001, Brazil

  • Antiguo Hospital Civil de Guadalajara Fray Antonio Alcalde

    Guadalajara, Jalisco, 44280, Mexico

  • Aou Citta della Salute e della Scienza di Torino - SC Dermatologia U

    Torino, 10126, Italy

  • Azienda Ospedaliera Santa Croce i Carle

    Cuneo, 12100, Italy

  • Azienda Ospedaliero Universitaria Pisana

    Pisa, Tuscany, 56126, Italy

  • Azienda Ospedaliero-Universitaria Maggiore della Carita - Oncology

    Novara, 28100, Italy

  • Azienda Sanitaria Universitaria del Friuli Centrale

    Udine, 33100, Italy

  • Azienda Socio Sanitaria Territoriale (ASST) degli Spedali Civili di Brescia

    Brescia, 25123, Italy

  • Baskent University

    Yüreğir, Adana, 01230, Turkey (Türkiye)

  • Besancon Regional University Hospital Center

    Besançon, Doubs, 25000, France

  • Bezmialem University

    Istanbul, Turkey, 34093, Turkey (Türkiye)

  • Bradford Hill

    Santiago, 8940575, Chile

  • CHU Charles Nicolle

    Rouen, Normandy, 76031, France

  • CHU Estaing

    Clermont-Ferrand, 63003, France

  • CHU de St Etienne

    Saint Priest En Jarez, Pays de la Loire Region, 42270, France

  • CHU-Dijon

    Dijon, Burgundy, 21000, France

  • Calvary North Adelaide Hospital

    North Adelaide, South Australia, 5006, Australia

  • Campus Bio-Medico di Roma

    Rome, 00128, Italy

  • Cancer Center of Adjara

    Batumi, 6000, Georgia

  • Cape Town Oncology Trials

    Cape Town, Western Cape, 7570, South Africa

  • Cardiomed

    Cluj-Napoca, Cluj, 400015, Romania

  • Catalan Institute Of Oncology

    Girona, 17007, Spain

  • Catalan Institute of Oncology (ICO) Hospitalet

    Barcelona, 08908, Spain

  • Catarina Pesquisa Clinica

    Itajaí, Santa Catarina, 88301-220, Brazil

  • Centre Hospitalier Le Mans

    Le Mans, Pays de la Loire Region, 72037, France

  • Centre Hospitalier Universitaire (CHU) de Lille

    Lille, Hauts-de-France, 59000, France

  • Centre Hospitalier Universitaire De Poitiers

    Poitiers, New Aquitaine, 86000, France

  • Centre Hospitalier Universitaire Grenoble Alpes

    La Tronche, Isere, 38700, France

  • Centre Hospitalier Universitaire Universite Catholique de Louvain Namur Site Sainte Elisabeth

    Namur, B5000, Belgium

  • Centre Leon Berard

    Lyon, 69008, France

  • Centro De Atencion E Investigacion Clinica En Oncologia SCP

    Mérida, Yucatán, 97134, Mexico

  • Centro De Estudios Y Prevention Del Cancer

    Tuxtla Gutiérrez, Chiapas, 29038, Mexico

  • Centro Estatal de Cancerologia

    Chihuahua City, 31000, Mexico

  • Centro Integral Oncologico HM Clara Campal

    Madrid, 28050, Spain

  • Centro Medico Austral

    Ciudad Autonoma de Buenos Aires, Buenos Aires, 1408, Argentina

  • Centro Medico Monte Carmelo

    Arequipa, 054, Peru

  • Centro Oncologia de Precision Universidad Mayor

    Santiago, Santiago Metropolitan, 7560907, Chile

  • Centro Oncologico del Norte

    Antofagasta, 1240000, Chile

  • Centro de Investigacion Pergamino

    Pergamino, Buenos Aires, B2700CPM, Argentina

  • Centro de Investigaciones Medicas y Desarrollo LC S.R.L. (LC Investigacion)

    Buenos Aires, 1125, Argentina

  • Centro de Pesquisa em Oncologia PUCRS

    Porto Alegre, Rio Grande do Sul, 90619900, Brazil

  • Centrul De Oncologie Euroclinic

    Iași, 7000106, Romania

  • Charite Universitaetsmedizin Berlin

    Berlin, 10117, Germany

  • Chu De Bordeaux

    Bordeaux, Gironde, 33075, France

  • Clinica Internacional SA

    Lima, 15036., Peru

  • Clinica Oncosalud

    San Borja, Lima region, 41, Peru

  • Clinica Peruano Americana (Private practice)

    Trujillo, La Libertad, 13001, Peru

  • Clinique Sainte Anne

    Strasbourg, 67000, France

  • Cliniques Universitaires Saint-Luc

    Brussels, 1200, Belgium

  • Cochin Hospital

    Paris, Île-de-France Region, 75014, France

  • Cork University Hospital

    Cork, T12 EC8P, Ireland

  • Cross Cancer Institute

    Edmonton, Alberta, T6G172, Canada

  • DIABAID - Instituto de Asistencia Integral en Diabetes

    Ciudad Autonoma de Buenos Aires, Buenos Aires, 1061, Argentina

  • Dermatologie

    Dessau, Saxony-Anhalt, 06847, Germany

  • Dicle University - Medical Faculty Campus

    Diyarbakır, 21200, Turkey (Türkiye)

  • Dr. Everett Chalmers Hospital

    Fredericton, New Brunswick, E3B 5N5, Canada

  • Ege University

    Izmir, Bornova, 35100, Turkey (Türkiye)

  • Elbekliniken Stade Buxtehude

    Buxtehude, Lower Saxony, 21614, Germany

  • Exelsus

    San Miguel de Tucumán, 4000, Argentina

  • FAICIC S. de R.L. de C.V.

    Veracruz, 91910, Mexico

  • FPO IRCCS Candiolo

    Candiolo, Torino, 10060, Italy

  • Fachklinik Hornheide

    Münster, North Rhine-Westphalia, 48157, Germany

  • Fn Kralovske Vinohrady, Dermatological Clinic

    Vinohrady, Prague, 10034, Czechia

  • Fondazione IRCCS Istituto Nazionale dei Tumori.

    Milan, 20133, Italy

  • Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto

    São José do Rio Preto, São Paulo, 15090-000, Brazil

  • Fundacao Pio XII - Hospital de Amor

    Barretos, São Paulo, 14784400, Brazil

  • Fundacao Pio XII - Hospital de Amor Amazonia

    Porto Velho, Rondônia, 76834-899, Brazil

  • Galway University Hospital

    Galway, Connacht, H91 YR71, Ireland

  • Gaziantep Medicalpoint Hospital

    Gaziantep, Sehitkamil, 27584, Turkey (Türkiye)

  • Gold Coast Hospital and Health Service

    Southport, Queensland, 4215, Australia

  • Groote Schuur Hospital

    Cape Town, Western Cape, 7925, South Africa

  • Gulhane Training and Research Hospital

    Ankara, 06010, Turkey (Türkiye)

  • Gustave Rroussy

    Villejuif, Val de Marne / Ile de France, 94805, France

  • H. Germans Trias i Pujol, ICO-Badalona

    Badalona, Barcelona, 08916, Spain

  • Helios Kliniken Schwerin

    Schwerin, 19055, Germany

  • Helios Klinikum Erfurt

    Erfurt, Thuringia, D-99089, Germany

  • Hemomed

    São Paulo, 01236030, Brazil

  • Hopital Ambroise Pare

    Boulogne, 92104, France

  • Hopital Avicenne

    Bobigny, Île-de-France Region, 93000, France

  • Hospices Civils de Lyon

    Pierre-Bénite, Auvergne-Rhône-Alpes, 69495, France

  • Hospital Bruno Born

    Lajeado, Rio Grande do Sul, 95900-022, Brazil

  • Hospital Clinico Universidad de Chile

    Santiago, Independencia, 8380456, Chile

  • Hospital Clinico Universitario Virgen De La Arrixaca

    El Palmar, Murcia, 30120, Spain

  • Hospital General Universitario Gregorio Maranon

    Madrid, 28007, Spain

  • Hospital Goyeneche

    Arequipa, 04000, Peru

  • Hospital Henri Mondor

    Créteil, Île-de-France Region, 94000, France

  • Hospital Moinhos de vento

    Porto Alegre, Rio Grande do Sul, 90440140, Brazil

  • Hospital Nacional Daniel A. Carrion

    Lima, Provincia Constitucional del Callao, 07016, Peru

  • Hospital Regional Universitario de Malaga

    Málaga, 29011, Spain

  • Hospital Sao Rafael

    Salvador, Estado de Bahia, 41253900, Brazil

  • Hospital Sirio Libanes

    São Paulo, 01308-050, Brazil

  • Hospital Teresa Herrera-Chuac

    A Coruña, Spain/La Coruna, 15006, Spain

  • Hospital Universitario Central de Asturias

    Oviedo, Principality of Asturias, 33011, Spain

  • Hospital Universitario Fundacion Jimenez Diaz

    Madrid, 28040, Spain

  • Hospital Universitario La Pa<

    Madrid, 28046, Spain

  • Hospital Universitario Lucus Augusti

    Lugo, 27003, Spain

  • Hospital Universitario Ramon y Cajal

    Madrid, 28034, Spain

  • Hospital Universitario Reina Sofia

    Córdoba, Andalusia, 14004, Spain

  • Hospital Universitario Virgen Macarena

    Seville, 41009, Spain

  • Hospital Universitario Virgen de las Nieves

    Granada, 18014, Spain

  • Hospital das Clinicas da Universidade Federal de Minas Gerais

    Belo Horizonte, Minas Gerais, 30130-090, Brazil

  • Hospital de Clinicas de Porto Alegre

    Porto Alegre, Rio Grande do Sul, 90035007, Brazil

  • Hospital de la Santa Creu i Sant Pau

    Barcelona, 8025, Spain

  • Hull University Teaching Hospitals NHS Trust

    Cottingham, East Yorkshire, HU16 5JQ, United Kingdom

  • INCA - Brazilian National Cancer Institute

    Rio de Janeiro, 20220-280, Brazil

  • IRCCS Casa Sollievo della Sofferenza

    San Giovanni Rotondo, Foggia, 71013, Italy

  • IRCCS Ospedale Policlinico San Martino

    Genoa, Liguria, 16132, Italy

  • IRCCS Regina Elena National Cancer Institute

    Rome, 00144, Italy

  • Icon Cancer Centre Hobart

    Hobart, Tasmania, 7000, Australia

  • Incliva - Instituto de Investigacion Sanitaria

    Valencia, 46010, Spain

  • Institute of Oncology Bucharest

    Bucharest, Bucharest, 022328, Romania

  • Instituto COI

    Rio de Janeiro, 23793-080, Brazil

  • Instituto Joinvilense de Hematologia e Oncologia

    Joinville, Santa Catarina, 89201260, Brazil

  • Instituto Nacional de Enfermedades Neoplasicas

    Surquillo, Lima region, 34, Peru

  • Instituto Oncologico Dr Rosell Hospital Universitari Quiron Dexeus Location

    Barcelona, Catalonia, 08028, Spain

  • Instituto Regional de Enfermedades Neoplasicas del Centro - IREN CENTRO

    Concepción, Departamento de Junín, 12125, Peru

  • Instituto Valenciano de Oncologia

    Valencia, 46009, Spain

  • Instituto de Oncologia de Rosario

    Rosario, Santa Fe Province, S2000KZE, Argentina

  • Instituto do Cancer em Hospital Sao Vicente de Paulo

    Passo Fundo, Rio Grande do Sul, 99010-090, Brazil

  • Investigacion Biomedica para el Desarrollo de Farmacos SA de CV

    Zapopan, Jalisco, 45070, Mexico

  • Israeli Georgian Medical Research Clinic Helsicore

    Tbilisi, 0112, Georgia

  • Istanbul Medeniyet University - Prof Dr Suleyman Yalcin Sehir Hospital

    Istanbul, 81450, Turkey (Türkiye)

  • Istanbul University Cerrahpasa at Cerrahpasa Medical Faculty

    Istanbul, 34450, Turkey (Türkiye)

  • Istituto Clinico Humanitas

    Rozzano, Milan, 20089, Italy

  • Istituto Dermopatico dell'Immacolata

    Rome, 00167, Italy

  • Istituto Europeo di Oncologia

    Milan, 20141, Italy

  • Istituto Nazionale Tumori IRCCS Fondazione G Pascale

    Naples, 80131, Italy

  • Istituto dei Tumori

    Bari, 70124, Italy

  • JSC K. Eristavi National Center of Experimental and Clinical Surgery

    Tbilisi, 0159, Georgia

  • Klinikum Nurnberg, Hautklinik, Universitatsklinik fur Dermatologie der Paracelsus Medizinischen Privatuniversitat

    Nuremberg, Bavaria, 90408, Germany

  • Kocaeli University

    İzmit, Kocaeli, 41380, Turkey (Türkiye)

  • LMU Klinikum

    Munich, Bavaria, 80337, Germany

  • LTD New Hospitals

    Tbilisi, 0114, Georgia

  • Leeds Teaching Hospitals NHS Trust

    Leeds, West Yorkshire, LS6 2HA, United Kingdom

  • Liga Paranaense de Combate ao Cancer - Hospital Erasto Gaertner

    Curitiba, Paraná, 81520-060, Brazil

  • Maria Sklodowska-Curie National Research Institute of Oncology

    Warsaw, 02-781, Poland

  • Mazowiecki Szpital Wojewodzki, Siedleckie Centrum Onkologii

    Siedlce, Mazxowieckie, 08-110, Poland

  • Medical University Innsbruck

    Innsbruck, Tyrol, 6020, Austria

  • Medical University Vienna

    Vienna, 1090, Austria

  • Medical University of Graz

    Graz, Styria, 8036, Austria

  • Medical oncology

    Istanbul, Bakirkoy, 34147, Turkey (Türkiye)

  • Medisprof

    Cluj-Napoca, Cluj, 400124, Romania

  • Memorial Ankara Hospital

    Ankara, 0906520, Turkey (Türkiye)

  • Nantes University Hospital

    Nantes, 44000, France

  • Netherlands Cancer Institute

    Amsterdam, 1066 CX, Netherlands

  • Neurociencias Estudios Clinicos SC

    Culiacán, Sinaloa, 80020, Mexico

  • Oncocenter Oncologie Clinica S.R.L

    Timișoara, Timiș County, 300166, Romania

  • Oncocentro APYS

    Viña del Mar, Valparaiso, 2520598, Chile

  • Oncomed

    Timișoara, Timiș County, 300239, Romania

  • Oncosite Centro De Pesquisa Em Oncologia

    Ijuí, 98700-000, Brazil

  • Oncovida

    Santiago, Santiago Metropolitan, Providencia, Chile

  • Onkologikoa

    Donostia / San Sebastian, Gipuzkoa, 20014, Spain

  • Orlando Health

    Orlando, Florida, 32806, United States

  • Ozel Liv Hospital

    Ankara, 06100, Turkey (Türkiye)

  • Poznan University of Meidcla Science

    Poznan, Wielkopolska, 60-788, Poland

  • Preparaciones Oncologica SC

    León, Guanajuato, 37178, Mexico

  • Princess Margaret Cancer Centre

    Toronto, Ontario, M5G 2M9, Canada

  • Radiotherapy Center Cluj

    Floreşti, Cluj, 407280, Romania

  • Regional Institute of Oncology

    Iași, 700383, Romania

  • Royal Devon and Exeter Hospital NHS Trust

    Exeter, Devon, EX2 5DW, United Kingdom

  • Royal Surrey County Hospital

    Guildford, GU2 7XX, United Kingdom

  • Royal Victoria Regional Health Centre

    Barrie, Ontario, L4M 6M2, Canada

  • Ruhr University Bochum

    Bochum, North Rhine-Westphalia, 44791, Germany

  • SC RTC Radiology Therapeutic Center SRL

    Otopeni, Ilfov, 075100, Romania

  • Santa Chiara Hospital

    Trento, 38122, Italy

  • Sao Camilo Oncologia

    São Paulo, 04014-002, Brazil

  • Seidman Cancer Center

    Cleveland, Ohio, 44106, United States

  • Sfantul Nectarie Oncology Center

    Craiova, Dolj, 200347, Romania

  • Skin Cancer Center Harz

    Quedlinburg, Saxony-Anhalt, 06484, Germany

  • St Vincents University Hospital

    Dublin, DO4YN63, Ireland

  • Sunnybrook Health Sciences Centre

    Toronto, Ontario, M4N 3M5, Canada

  • Szabolcs Szatmar Bereg Megyei Korhazak Es Egyetemi Oktatokorhaz

    Nyíregyháza, Szabolcs-Szatmár-Bereg, 4400, Hungary

  • TIM - Tbilisi Institute of Medicine

    Tbilisi, 0160, Georgia

  • Tallaght University Hospital

    Dublin, D24NROA, Ireland

  • Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic

    Tbilisi, 0144, Georgia

  • The Angeles Clinic and Research Institute

    Los Angeles, California, 90025, United States

  • The Medical Oncology Centre of Rosebank

    Johannesburg, Gauteng, 2196, South Africa

  • Townsville University Hospital

    Townsville, Queensland, 4814, Australia

  • Trakya University

    Edirne, 22030, Turkey (Türkiye)

  • U.O.C. Oncologia Medica ed Ematologia (U.O.C Medical Oncology and Hematology)

    Naples, Campania, 80121, Italy

  • UC San Diego

    La Jolla, California, 92093, United States

  • Universita Degli Studi Di Milano-Bicocca - Azienda Ospedaliera San Gerardo Di Monza

    Monza, 20052, Italy

  • Universitatsklinikum Leipzig, AoR

    Leipzig, Saxony, 04103, Germany

  • Universitatsklinikum Schleswig Holstein Campus Luebeck

    Lübeck, Schleswig-Holstein, 23538, Germany

  • Universitatsmedizin der Johannes-Gutenberg Universitat Mainz

    Mainz, Rhineland-Palatinate, 55131, Germany

  • University Clinic Frankfurt

    Frankfurt am Main, Hesse, 60590, Germany

  • University Hospital Dresden

    Dresden, Saxony, 01307, Germany

  • University Hospital Giessen

    Giessen, Hesse, 35385, Germany

  • University Hospital Hradec Kralove

    Hradec Králové, North Central Czech Republic, 50005, Czechia

  • University Hospital Ostrava

    Ostrava, 70852, Czechia

  • University Hospital Saint Poelten

    Sankt Pölten, Lower Austria, 3100, Austria

  • University Hospital of Regensburg

    Regensburg, Bavaria, 93053, Germany

  • University Hospital of Universitatsklinikum Schleswig Holstein (UKSH) Campus Kiel

    Kiel, Schleswig-Holstein, 24105, Germany

  • University Medical Center Gottingen

    Göttingen, 37075, Germany

  • University Medical Center Mannheim

    Mannheim, Baden-Wurttemberg, 68167, Germany

  • University Medical Centre Groningen

    Groningen, 9713 GZ, Netherlands

  • University of Debrecen

    Debrecen, Hajdú-Bihar, H-4032, Hungary

  • University of Pecs Medical School

    Pécs, Baranya, 7632, Hungary

  • University of Tennessee Medical Center

    Knoxville, Tennessee, 37920, United States

  • University of Tuebingen

    Tübingen, Baden-Wurttemberg, 72076, Germany

  • Uniwersyteckie Centrum Kliniczne (UCK)

    Gdansk, Pomeranian Voivodeship, 80-214, Poland

  • Vento Institute of Oncology IOV-IRCCS

    Padova, 35128, Italy

  • Wojewodzki Szpital Specjalistyczny im. Janusza Korczaka w Slupsku Sp. z o.o.

    Słupsk, Pomeranian, 76-200, Poland

  • iCan Oncology

    Monterrey, Nuevo León, 64710, Mexico

  • ltd Multiprofile Clinic Consilium Medulla

    Tbilisi, 186, Georgia

More trials for these conditions

Other studies related to the condition(s) this trial covers.